A previous study showed effective antitumor responses in OC by targeting B7H3 via chimeric antigen receptor T cells, which is similar to our findings that B7H3-redirecting BiTE can significantly induce tumor killing in vitro and in vivo20. The gene discussed is CEP70; the disease is neoplasm.